Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-2025-04-21

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Rimonabant

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,430Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Corbus Pharmaceuticals Starts Phase 1 Study of CRB-913 for Obesity
    Corbus Pharmaceuticals Starts Phase 1 Study of CRB-913 for Obesity

    28 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/28/3051321/0/en/Corbus-Pharmaceuticals-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Study-of-Next-Generation-CB1-Inverse-Agonist-CRB-913-for-the-Treatment-of-Obesity.html

    GLOBENEWSWIRE
    28 Mar 2025
    Share Share
    EU extends Ozempic review to include more weight-loss, diabetes drugs
    EU extends Ozempic review to include more weight-loss, diabetes drugs

    13 Jul 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/eu-extends-ozempic-probe-include-other-drugs-2023-07-11/

    REUTERS
    13 Jul 2023
    Share Share
    Belviq Study Results May Improve The Fortunes Of Weight-Loss Drugs
    Belviq Study Results May Improve The Fortunes Of Weight-Loss Drugs

    11 Sep 2018

    // Joshua Cohen FORBES

    https://www.forbes.com/sites/joshuacohen/2018/09/10/belviq-study-results-may-improve-the-fortunes-of-weight-loss-drugs/#2cefd3836a40

    Joshua Cohen FORBES
    11 Sep 2018
    Share Share
    Eisai Gets EMA Nod For Lenvima Just Weeks After FDA Approval
    Eisai Gets EMA Nod For Lenvima Just Weeks After FDA Approval

    28 Mar 2015

    // Eric Palmer FIERCE PHARMA

    http://www.fiercepharma.com/story/eisai-gets-ema-nod-lenvima-just-weeks-after-fda-approval/2015-03-27

    Eric Palmer FIERCE PHARMA
    28 Mar 2015
    Share Share
    Is Europe Softening on Diet Drugs?
    Is Europe Softening on Diet Drugs?

    28 Mar 2015

    // Kristina Fiore MEDPAGE TODAY

    http://www.medpagetoday.com/Endocrinology/Diabetes/50672?xid=nl_mpt_DHE_2015-03-27&eun=g655567d0r&userid=655567&mu_id=5789356

    Kristina Fiore MEDPAGE TODAY
    28 Mar 2015
    Share Share